BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2676819)

  • 1. Different effects of duration on prevalence of anti-adrenal medullary and pancreatic islet cell antibodies in type I diabetes mellitus.
    Brown FM; Vinik AI; Ganda OP; Adri MN; Rabinowe SL
    Horm Metab Res; 1989 Aug; 21(8):434-7. PubMed ID: 2676819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-adrenal medullary antibodies in IDDM subjects and subjects at high risk of developing IDDM.
    Brown FM; Kamalesh M; Adri MN; Rabinowe SL
    Diabetes Care; 1988 Jan; 11(1):30-3. PubMed ID: 3276475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of antibodies against pancreatic islet cells in clinical practice].
    Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
    Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Islet cell cytoplasmic antibodies (ICA) and complement-fixing islet cell cytoplasmic antibodies (CF-ICA) in patients with newly detected type 1 diabetes mellitus of short duration].
    Majkowska L
    Ann Acad Med Stetin; 1990; 36():95-111. PubMed ID: 2099111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of islet cell surface antibodies using cloned beta cells and comparison of their incidence with that of islet cell cytoplasmic antibodies.
    Grant AM; Harrison DE; Moysey L; Smith D; Ashcroft SJ
    Diabetes Res; 1985 Sep; 2(5):225-9. PubMed ID: 3905186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cytoplasmic islet-cell antibodies (ICA) and cytoplasmic complement- fixing antibodies (CF-ICA) in patients with newly detected and short-lasting diabetes mellitus type 1].
    Majkowska L; Czekalski S; Skwira J
    Pol Tyg Lek; 1990 May 7-14; 45(19-20):384-8. PubMed ID: 2255656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The combination of antibodies to GAD-65 and IA-2ic can replace the islet-cell antibody assay to identify subjects at risk of type 1 diabetes mellitus.
    Hatziagelaki E; Jaeger C; Petzoldt R; Seissler J; Scherbaum WA; Federlin K; Bretzel RG
    Horm Metab Res; 1999 Oct; 31(10):564-9. PubMed ID: 10596966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Islet autoantibodies, nationality and gender: a multinational screening study in first-degree relatives of patients with Type I diabetes.
    Williams AJ; Bingley PJ; Moore WP; Gale EA;
    Diabetologia; 2002 Feb; 45(2):217-23. PubMed ID: 11935153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human islet cell antibodies: immunoglobulin class and subclass distribution defined by monoclonal antibodies.
    Omar MA; Srikanta S; Eisenbarth GS
    Diabetes Res; 1987 Apr; 4(4):155-7. PubMed ID: 3304781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoplasmic islet cell antibodies in type I diabetics in Israel and their first-degree relatives.
    Assa S; Karp M; Erster B; Laron Z
    Isr J Med Sci; 1985 Sep; 21(9):727-30. PubMed ID: 3902719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
    Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF
    J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epidemiologic studies of the recognition of the preclinical phase of type I diabetes in school children].
    Seissler J; Glück M; Speck U; Yassin N; Fetzer A; Bornstein S; Hauner H; Heinze E; Scherbaum WA
    Dtsch Med Wochenschr; 1990 May; 115(18):689-94. PubMed ID: 2185925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Giessen-Bad Oeynhausen family study: improved prediction of type I diabetes in a low incidence population of relatives using combinations of islet autoantibodies in a dual step model.
    Jaeger C; Hatziagelaki E; Stroedter A; Becker F; Scherer S; Petzoldt R; Federlin K; Bretzel RG
    Exp Clin Endocrinol Diabetes; 1999; 107(8):496-505. PubMed ID: 10612480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Islet antibodies associated with pancreatic B-cell dysfunction at and 3 years after diagnosis of diabetes in subjects aged 35-64 years old: degree of impairment less severe than in those aged 0-34 years old.
    Berger B; Borg H; Fernlund P; Stenström G; Sundkvist G
    Diabet Med; 2006 Nov; 23(11):1180-5. PubMed ID: 17054592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for specific autoimmunity against sympathetic and parasympathetic nervous tissues in Type 1 diabetes mellitus and the relation to cardiac autonomic dysfunction.
    Muhr-Becker D; Ziegler AG; Druschky A; Wolfram G; Haslbeck M; Neundörfer B; Standl E; Schnell O
    Diabet Med; 1998 Jun; 15(6):467-72. PubMed ID: 9632120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined analysis of long-term anti-beta-cell humoral reactivity in type 1 diabetes with and without thyroid disease.
    Maugendre D; Sonnet E; Derrien C; Le Golff MC; Grais MC; Allannic H; Delamaire M
    Diabetes Metab; 1999 Mar; 25(1):28-33. PubMed ID: 10335421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of islet cell antibodies and B cell functional status in insulin dependent diabetes.
    Merchant PC; Godse CS; Varthakavi PK; Patel KL; Nihalani KD
    J Assoc Physicians India; 1996 Jul; 44(7):457-60. PubMed ID: 9282605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement-fixing antibodies to sympathetic and parasympathetic tissues in IDDM. Autonomic brake index and heart-rate variation.
    Rabinowe SL; Brown FM; Watts M; Smith AM
    Diabetes Care; 1990 Oct; 13(10):1084-8. PubMed ID: 1698597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-glucagon-cell and anti-adrenal-medullary-cell antibodies in islet-cell-autoantibody-positive diabetic children.
    Schopfer K; Matter L; Tenschert R; Bauer S; Zuppinger K
    N Engl J Med; 1984 Jun; 310(23):1536-7. PubMed ID: 6371538
    [No Abstract]   [Full Text] [Related]  

  • 20. Limited loss of tolerance to islet autoantigens in ICA+ first degree relatives of patients with type I diabetes expressing the HLA dqb1*0602 allele.
    Gianani R; Verge CF; Moromisato-Gianani RI; Yu L; Zhang YJ; Pugliese A; Eisenbarth GS
    J Autoimmun; 1996 Jun; 9(3):423-5. PubMed ID: 8816981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.